Katerina Politi

12PUBLICATIONS
152CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 06, 2025
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-type Non-Small Cell Lung Cancer.

Ioannis P Trontzas, Mengni He, Anna Wurtz

|Nov 25, 2024
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer.

Camila Robles-Oteíza, Katherine Hastings, Jungmin Choi

|Feb 15, 2024
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.

Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel

|Jan 25, 2024
EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth.

Alexandra Kuhlmann-Hogan, Thekla Cordes, Ziyan Xu

|Jan 19, 2024
EGFR-driven lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth.

Alexandra Kuhlmann-Hogan, Thekla Cordes, Ziyan Xu

Pageof 2